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Abstract
Pharmacological methods to assess baroreflex sensitivity evoke supra-physiological blood pressure changes whereas
computational methods use spontaneous fluctuations of blood pressure. The relationships among the different baroreflex
assessment methods are still not fully understood. Although strong advocates for each technique exist, the differences
between these methods need further clarification. Understanding the differences between pharmacological and
spontaneous baroreflex methods could provide important insight into the baroreflex physiology. We compared the
modified Oxford baroreflex gain and the transfer function modulus between spontaneous RR interval and blood pressure
fluctuations in 18 healthy subjects (age: 39610 yrs., BMI: 2664.9). The transfer function was calculated over the low-
frequency range of the RR interval and systolic blood pressure oscillations during random-frequency paced breathing. The
average modified Oxford baroreflex gain was lower than the average transfer function modulus (15.769.2 ms/mmHg vs.
19.4610.5 ms/mmHg, P,0.05). The difference between the two baroreflex measures within the individual subjects
comprised a systematic difference (relative mean difference: 20.7%) and a random variance (typical error: 3.9 ms/mmHg).
The transfer function modulus gradually increased with the frequency within the low-frequency range (LF), on average from
10.467.3 ms/mmHg to 21.269.8 ms/mmHg across subjects. Narrowing the zone of interest within the LF band produced a
decrease in both the systematic difference (relative mean difference: 0.5%) and the random variance (typical error: 2.1 ms/
mmHg) between the modified Oxford gain and the transfer function modulus. Our data suggest that the frequency
dependent increase in low-frequency transfer function modulus between RR interval and blood pressure fluctuations
contributes to both the systematic difference (bias) and the random variance (error) between the pharmacological and
transfer function baroreflex measures. This finding suggests that both methodological and physiological factors underlie the
observed disagreement between the pharmacological and the transfer function method. Thus both baroreflex measures
contribute complementary information and can be considered valid methods for baroreflex sensitivity assessment.
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Introduction
The baroreflex provides prompt reflex changes in heart rate and
peripheral resistance, thereby buffering the blood pressure
perturbations that occur in response to physiological or environ-
mental provocations. Baroreflex sensitivity, defined as the reflex
changes in heart period (RR interval) in response to changes in
blood pressure, is the most frequently used characteristic of the
baroreflex. Decreased baroreflex sensitivity is a feature of several
disorders of the cardiovascular [1–3] and autonomic nervous
system [4–6]. Baroreflex dysfunction is also a prognostic factor in
several cardiovascular diseases [3,7–13]. Estimation of baroreflex
sensitivity is therefore an important component of autonomic and
cardiovascular research and may have serious clinical implications.
Although several techniques for baroreflex assessment are
available and are widely used, there is no gold standard method
for baroreflex assessment [14,15].
Pharmacological methods to assess baroreflex sensitivity evoke
supra-physiological blood pressure change as the input signal and
the subsequent change in RR interval is analysed as function of
blood pressure [16–18]. In contrast, computational methods such
as the sequence and spectral methods use the much smaller
spontaneous variations of blood pressure and RR interval for
baroreflex assessment [19–22]. While large pressure changes
evoked by pharmacological methods clearly cause baroreflex
engagement, studies have also confirmed the role of the baroreflex
in the interaction between spontaneous blood pressure and RR
interval oscillations [23,24]. Reports have also suggested that the
low-frequency spontaneous RR interval changes are predomi-
nantly mediated by the baroreflex whereas the high-frequency RR
interval and blood pressure oscillations may have concurrent
mechanical and neural mechanisms [11,23,25–28].
Despite the extensive use of pharmacological and spontaneous
baroreflex methods to assess baroreflex sensitivity, the relationship
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between these methods is not fully elucidated. Previous studies
comparing pharmacological and spontaneous baroreflex measures
showed moderate [29–32] or high [19,33] linear association
between the two methods but the pharmacological and sponta-
neous baroreflex measures generally had a weak agreement within
the individual subjects. Although no systematic investigation has
been performed, it is likely that both methodological and
physiological factors play a role in the weak agreement between
the pharmacological and spontaneous baroreflex methods [22].
The difference between two measurements comprises a
systematic and a random factor [34–37]. The systematic difference
or bias is a general trend for measurements to be different in a
particular direction and usually originates from methodological or
treatment effects, whereas the random variance or error is caused
by unpredictable biological and technical variability that occurs
between the measurements.
In the present study we compared two frequently used
techniques for baroreflex assessment, the RR interval response
to sequential pharmacological manipulation of blood pressure (the
modified Oxford method) [38] and the transfer function analysis
between the spontaneous RR interval and blood pressure
oscillations [19,22]. Although it is recognized that the modulus
of the transfer function between spontaneous RR interval and
blood pressure oscillations, the measure of baroreflex sensitivity,
shows frequency dependency [19,39], and even within the low-
frequency band the modulus increases as function of frequency
[40,41], the role played by this phenomenon in producing the
difference between the modified Oxford and the transfer function
assessment methods has not been analysed.
We sought to elucidate the methodological and physiological
factors that underlie the weak agreement between the pharmaco-
logical and spontaneous baroreflex measures within the individual
subjects. We hypothesized that the frequency dependence of the
modulus of the transfer function between spontaneous RR interval
and blood pressure was a major contributor to the difference
between the modified Oxford and the transfer function baroreflex
assessment methods.
Subjects and Methods
Subjects
Eighteen healthy subjects (12 females, 6 males) participated in
the study. All subjects were free from any acute illness or chronic
disease. The study was performed in accordance with the
Declaration of Helsinki of the World Medical Association and
the protocol was approved by the Institutional Review Board of
the Beth Israel Deaconess Medical Center. All subjects provided
written informed consent prior to the study.
Protocol
Subjects were studied in supine position, in the morning after a
light breakfast. Heart rate, RR interval, respiration and blood
pressure were monitored throughout the study. Respiratory
pattern was recorded with a two-belt chest-abdomen inductance
plethysmograph (Respitrace Ambulatory Monitoring). Blood
pressure was continuously measured on the finger by Finapres
(Model 2300, Ohmeda) and intermittently measured with
oscillometry (Dinamap). On consecutive days, baroreflex sensitiv-
ity was estimated by the modified Oxford technique and by the
analysis of transfer function between spontaneous RR interval and
blood pressure fluctuations.
Baroreflex sensitivity assessment
To perform the modified Oxford test, an intravenous catheter
was inserted into an antecubital vein for drug administration. After
a resting period of 30 min, a 5-min baseline recording was made
and then followed by the baroreflex test: Sequential administration
of bolus injections of 100 mg sodium nitroprusside and of 150 mg
phenylephrine hydrochloride produced a drop in pressure of
,15 mmHg below baseline followed by pressure rise of
,15 mmHg above baseline (Figure 1) [38]. We performed the
baroreflex test at least twice with a 15-minute recovery period
between trials to allow heart rate and blood pressure to return to
the normal values.
For spontaneous baroreflex assessment, we used the transfer
function between RR interval and blood pressure oscillations over
the low-frequency band as it is thought to be predominantly
determined by the baroreflex. The transfer function method has
been described in detail previously [39,42]. Briefly, after a 30-min
resting period, the subjects performed a 7-min random-frequency
paced breathing protocol in which a breath was initiated with each
tone of a series of auditory cues spaced at irregular intervals
(Figure 2). The median breathing frequency was 0.2660.03 Hz
with an inter-quartile range of 0.2660.06 Hz, averaged across the
subjects. To minimize paced breathing related stress, the subjects
were trained to breathe in response to auditory cues prior to the
test. Also, to minimize the discomfort and hyperventilation, the
subjects were allowed to comfortably control the depth and shape
of each breath throughout the breathing protocols.
Data analysis
Baroreflex sensitivity in the modified Oxford method was
assessed by beat-to-beat RR interval plotted as a function of
systolic blood pressure between the lowest and the peak pressure
values (Figure 3). In 88% of subjects this revealed the entire
sigmoid nature of arterial baroreflex [18,43]. After extracting the
saturation and threshold regions, the slope of the linear part of
regression between RR interval and systolic blood pressure
provided the measure of baroreflex sensitivity [17]. Only
regressions with correlation coefficients r.0.7 were accepted.
For transfer function analysis the Blackman-Tukey method [44]
was used to calculate the power spectrum of RR interval and
systolic blood pressure. The relevant segments for spectral analysis
were 341 seconds (1024 samples at 3 Hz). The frequency range
0.0420.15 Hz was used to define the low-frequency band. The
transfer function between RR interval and systolic blood pressure
oscillations was calculated using the cross-spectra method
[26,42,45]. The transfer function modulus was estimated as the
mean value in the low-frequency range including only the
segments with coherence .0.5.
To account for the frequency dependent increase in the
modulus of the transfer function, the transfer function within the
low-frequency band was subdivided into segments encompassing
the 25th, 50th, 75th percentiles of the area under the modulus curve
(Figure 4). The mean transfer function modulus was calculated for
each of these segments within the low-frequency band.
Figure 1. Modified Oxford baroreflex test. ECG, RR interval and blood pressure recording during the modified Oxford baroreflex test in a
representative subject. Arrows indicate sodium nitroprusside (NP) and phenylephrine (PHE) bolus injections. Blood pressure fall is followed by a blood
pressure rise in response to the bolus injections.
doi:10.1371/journal.pone.0079513.g001
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Statistical analysis
The relation between the modified Oxford baroreflex gain and
the transfer function modulus was determined with the Pearson
correlation coefficient. Paired t-test was used to compare blood
pressure changes and baroreflex measures within the subjects.
To estimate the systematic difference (bias) and the random
variance (error) between the modified Oxford baroreflex gain and
the transfer function modulus, we used the concept for the
measures of reliability described by Hopkins [34] and Bland and
Altman [35].
The mean of the within-subject differences between the
modified Oxford gain and the transfer function modulus denotes
the systematic difference (bias) while the distribution of the within-
subject differences (typical error and limit of agreement) between
the two measures denotes the random variance between the two
methods. Figure 5 illustrates the reliability concept. The figure
displays two representative situations, one with large systematic
difference and large random variance between two methods and
one with small systematic difference and small random variance
between two methods (Figure 5).
The typical error between the two baroreflex measures is
calculated as the standard deviation (SD) of the within-subject
differences divided by !2 [34]. The limit of agreement between the
two baroreflex measures is calculated as the 95% likely range of
the within-subject differences [34].
In order to reduce any proportional effect of baroreflex
sensitivity on the within-subject differences between the two
measures, and to express both the systematic difference (bias) and
the random variance between the methods in relative terms, the
systematic difference and random variance were also calculated
from the logarithmically transformed data.
The systematic difference was expressed as the relative
difference (%) [34] using the formula:
Relative difference~
100 eAverage log mod Oxford gainf g{log transfer modulusf g½ {1
 
The random variance was also expressed as coefficient of
variation (%) [34]using the formula:
Coefficient of variation~
100 eSD log mod Oxford gainf g{log transfer modulusf g½ =
ﬃﬃ
2
p
{1
 
Results
Demographics and baseline parameters
The mean age of the subjects was 39610 years while the BMI of
the subjects was 2664.9 kg/m2. The average baseline resting
systolic blood pressure was 122612 mmHg; diastolic blood
pressure was 70610 mmHg; and RR interval and heart rate
were 10746159 ms and 5767 bpm.
Figure 2. Random-frequency paced breathing. Respiration, ECG, RR interval and blood pressure recording during the random-frequency
breathing protocol in a representative subject. Random-frequency breathing was used to broaden the frequency content of the respiratory signal for
transfer function analysis.
doi:10.1371/journal.pone.0079513.g002
Figure 3. Modified Oxford baroreflex assessment in a representative subject. For baroreflex sensitivity assessment RR interval is plotted as
a function of systolic blood pressure (SBP) between the lowest and the peak pressure values. The linear part of the sigmoid function describes the
baroreflex sensitivity (see Methods).
doi:10.1371/journal.pone.0079513.g003
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Figure 4. Transfer function modulus curve in the low-frequency region averaged for all subjects. Thick line displays average values, thin
lines display standard deviation of transfer function modulus. Shaded areas represent the segments calculated according to the 25th, 50th and 75th
percentiles of the transfer function modulus (see Methods).
doi:10.1371/journal.pone.0079513.g004
Figure 5. Systematic difference and random variance. Representation of the calculation of the systematic difference and random variance
between modified Oxford and transfer function baroreflex measures. Mean of the within-subject difference scores denotes systematic difference
(middle line). Standard deviation of within-subject difference scores divided by !2 denotes typical error. The 95% range of within-subject difference
scores denotes limit of agreement. Top panel: Large systematic difference and large random variance between two measures. Bottom panel: Small
systematic difference and small random variance between two measures.
doi:10.1371/journal.pone.0079513.g005
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Figure 6. Systematic difference and random variance between the modified Oxford gain and the transfer function moduli.
Systematic difference and random variance between modified Oxford baroreflex gain and the transfer function modulus calculated from the different
segment of the low-frequency range. LF25, LF50, LF75 denote the segments in which the transfer function modulus was calculated for the analysis.
LF100 denotes the entire low-frequency range between 0.04–0.15 Hz. Dashed lines represent mean difference and typical error. Dotted lines
represent limit of agreement.
doi:10.1371/journal.pone.0079513.g006
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Blood pressure change
The range of blood pressure changes for baroreflex assessment
was significantly different between the modified Oxford and the
transfer function methods. Using the modified Oxford method, the
range of systolic blood pressure change was 47618 mmHg while
using the transfer function method, the range of systolic blood
pressure change was 2469 mmHg (P,0.05).
Modified Oxford gain and transfer function modulus
There was strong correlation between the modified Oxford
baroreflex gain and the transfer function modulus among the
subjects (r = 0.85). Despite their correlation, however, the two
measures of baroreflex sensitivity differed considerably within
individual subjects. On average among the subjects, the transfer
function modulus was higher than the modified Oxford baroreflex
gain (19.4610.5 vs. 15.769.2, P,0.05).
The mean difference between the transfer function modulus and
the modified Oxford gain was 3.665.5 ms/mmHg; the mean
relative difference between the two baroreflex measures was
20.7%. The typical error between the transfer function modulus
and the modified Oxford baroreflex gain was 3.9 ms/mmHg, the
limit of agreement between the two baroreflex measures was
10.8 ms/mmHg. The coefficient of variation between the
modified Oxford baroreflex gain and the transfer function
modulus was 28.6% (see Figure 6 and Figure 7).
In comparison, the typical error between two consecutive
modified Oxford baroreflex gains was 6.7 ms/mmHg or 19.7%
expressed as coefficient of variation.
Frequency dependent increase of transfer function
modulus
Figure 4 shows the transfer function modulus as function of
frequency over the low-frequency range, averaged for all subjects.
The figure indicates that the transfer function modulus gradually
increases with the frequency. The average increase of the transfer
function modulus within the low-frequency band was
13.768.2 ms/mmHg across the subjects.
Figure 4 also illustrates the segmentation of the transfer function
modulus curve (see Methods).
The systematic difference and the random variance (typical
error and limit of agreement) between the modified Oxford gain
and the moduli of transfer function calculated over the different
segments of the low-frequency transfer function are displayed in
Figure 6 and Figure 7 and summarized in Table 1 and Table 2.
Both the systematic difference and the random variance between
the modified Oxford gain and the transfer function modulus
decreased when the modulus was calculated from lower (75th and
50th percentile) segments of the transfer function modulus curve
(Figure 6–7 and Table 1–2). The modulus, calculated over the 25th
percentile segment of the modulus curve, was lower than the
modified Oxford gain and the random variance between the two
measures increased slightly.
Comparison of transfer function modulus segments
Table 3 and Table 4 show the systematic difference and the
random variance between the low-frequency modulus calculated
over the entire low-frequency band (LF100) and the moduli
calculated over the 75th (LF75), 50th (LF50) and 25th (LF25)
segments. Both the systematic difference and the random variance
between the modulus from the entire low-frequency band (LF100)
and the modulus from a lower segment increased when the
modulus was calculated from a lower percentile segment of the
transfer function modulus curve. The corresponding frequency
limits for the 25th, 50th and 75th percentile segments of the low-
frequency transfer function modulus were 0.0760.02 Hz,
0.0960.02 Hz and 0.1260.02 Hz, averaged across the subjects.
Discussion
In the present study we analysed the difference between the
modified Oxford pharmacological baroreflex gain and the transfer
function modulus of spontaneous low-frequency RR interval and
blood pressure oscillations in healthy subjects. The main findings
are: 1) the difference between the modified Oxford baroreflex gain
and the low-frequency transfer function modulus between RR
interval and blood pressure oscillations comprises a systematic
difference (bias) and a random variance (error); 2) the systematic
difference between the modified Oxford baroreflex gain and the
low-frequency transfer function modulus decreases when the
region within the low-frequency band is constricted to the lower
segments; and 3) the random variance (error) between the
modified Oxford baroreflex gain and the low-frequency transfer
function modulus decreases as the systematic difference (bias)
between the two methods is decreased.
Although the modified Oxford gain and the transfer function
modulus correlate significantly across subjects, their values differ
considerably within the individual subjects. This difference
Figure 7. Bland-Altman plots of differences between modified Oxford baroreflex gain and transfer function moduli (y axis) and
mean of the two measures (x axis). Dashed line denotes mean difference; dotted line denotes limit of agreement (range within which an
individual’s difference scores would fall 95% of the time).
doi:10.1371/journal.pone.0079513.g007
Table 1. Systematic difference and random variance between modified Oxford baroreflex gain and transfer function modulus.
RAW DATA Modified Oxford gain versus
LF100 LF75 LF50 LF25
Mean difference [ms/mmHg] 23.6 (26.4, 20.9) 21.5 (23.4, 0.4) 20.07 (21.5, 1.4) 1.6 (3.0, 0.1)
Typical error [ms/mmHg] 3.9 (2.9, 5.8) 2.7 (2.0, 4.0) 2.1 (1.5, 3.0) 2.1 (1.6, 3.1)
Limit of agreement [ms/mmHg] 10.8 7.5 5.7 5.8
Values were calculated from raw data. Transfer function was obtained from random-frequency breathing. The moduli were calculated over the entire low-frequency
transfer function and over the different segments of the low-frequency transfer function (see Methods).
Values are expressed as means (95% Confidence Interval). LF100 denotes the transfer function modulus calculated over the entire low-frequency band. LF75, LF50 and
LF25 denote the transfer function modulus obtained from the respective percentile segments of the low-frequency transfer function (see Methods).
doi:10.1371/journal.pone.0079513.t001
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between the two baroreflex measures within the same subject has
two components, the systematic difference, or bias and random
variance or error [34,36].
Systematic difference
Consistent with prior studies, we show that the modified Oxford
baroreflex gain is smaller than the LF transfer function modulus
[46]. The significant difference in means between the modified
Oxford baroreflex gain and the transfer function modulus across
subjects represents the systematic difference between the two
baroreflex measures and denotes methodological or treatment
differences. There are several hypotheses to explain this systematic
difference. These include: (1) The different features of open loop
and closed loop system approach - the modified Oxford
pharmacological baroreflex test represents an open loop approach
of engaging the baroreflex system and thus the modified Oxford
baroreflex gain represents only feedback relation between the RR
interval and blood pressure. In contrast, the spontaneous
baroreflex method represents a closed loop condition including
both feedback and feed forward relations between RR interval and
blood pressure. The interaction of the feed forward and feedback
relations may change the measured baroreflex gain systematically
[39,43]. (2) Baroreflex resetting during blood pressure change -
rapid resetting of the baroreflex during induced blood pressure
changes could confound the measured baroreflex gain [43,46–49].
Because the time course of the drug-induced blood pressure
change is longer than that of the spontaneous pressure change,
baroreflex resetting is more likely occur during the modified
Oxford test [29,43]. (3) The different relative influences of the
sympathetic and parasympathetic systems evoked by the different
methods – in the pharmacological method the blood pressure drop
induced by the nitroprusside results in a rapid increase in
sympathetic activity that lasts until the blood pressure returns to
a normal level induced by the phenylephrine. The increased
sympathetic activity, which is much less prominent during
spontaneous decreases in pressure compared to drug-induced
decreases in pressure, may have an attenuating effect on the
measured baroreflex gain during the modified Oxford test [33]. (4)
Direct cardiac effects - both the nitroprusside and phenylephrine
used in the modified Oxford technique may have a direct effect on
the heart, which could systematically modify the relationship
between the RR interval and blood pressure. (5) The computation
of baroreflex sensitivity along the modified Oxford baroreflex
curve - fitting sigmoid or linear regression on the RR interval and
blood pressure data, used in the calculation of the gain in the
modified Oxford method, may also introduce a systematic
difference in the measured baroreflex gain [18,50].
Although we cannot exclude a contribution from these
mechanisms, the present data suggest that a methodological factor
in the transfer function analysis plays a major role in the systematic
difference between the modified Oxford and the transfer function
baroreflex measures. In accordance with other studies [29,40,41],
we found that the transfer function modulus between blood
pressure and RR interval oscillations gradually increased with the
frequency within the low-frequency band (see Figure 4). Since the
transfer function modulus is calculated as mean value over a
defined frequency range, the frequency related increase in
modulus may result in an overestimation of baroreflex sensitivity
compared to the modified Oxford gain. Our results support this
possibility. The calculation of transfer function modulus from the
Table 2. Systematic difference and random variance between modified Oxford baroreflex gain and transfer function modulus.
LOGARITHMIC DATA Modified Oxford gain versus
LF100 LF75 LF50 LF25
Relative difference [%] 220.7 (231.9, 22.9) 210.9 (223.4, 5.0) 0.5 (212.4,15.3) 15.9 (0.9, 36.3)
Coefficient of variation [%] 28.6 (23.9, 53.5) 25.1 (20.8, 45.8) 21.6 (17.6, 38.2) 23.8 (19.6, 42.9)
Values were calculated from logarithmically-transformed data. Transfer function was obtained from random-frequency breathing. The moduli were calculated over the
entire low-frequency transfer function and over the different segments of the low-frequency transfer function (see Methods).
Values are expressed as means (95% Confidence Interval). LF100 denotes the transfer function modulus calculated over the entire low-frequency band. LF75, LF50 and
LF25 denote the transfer function modulus obtained from the respective percentile segments of the low-frequency transfer function (see Methods).
doi:10.1371/journal.pone.0079513.t002
Table 3. Systematic difference and random variance between
the transfer function modulus calculated over the entire low-
frequency band and the moduli calculated over the segments
of the low-frequency transfer function.
RAW DATA LF100 versus
LF75 LF50 LF25
Mean difference [ms/
mmHg]
2.1 (0.9, 3.4) 3.6 (1.7, 5.4) 5.2 (2.6, 7.8)
Typical error [ms/mmHg] 1.7 (1.3, 2.6) 2.6 (1.9, 3.8) 3.7 (2.7, 5.5)
Limit of agreement [ms/
mmHg]
4.8 7.2 10.2
Values were calculated from raw data. Values are expressed as means (95%
Confidence Interval). LF75, LF50 and LF25 denote the transfer function modulus
obtained from the respective percentile segments of the low-frequency transfer
function (see Methods).
doi:10.1371/journal.pone.0079513.t003
Table 4. Systematic difference and random variance between
the transfer function modulus calculated over the entire low-
frequency band and the moduli calculated over the segments
of the low-frequency transfer function.
LOGARITHMIC
DATA LF100 versus
LF75 LF50 LF25
Relative difference [%]11.0 (6.5, 14.1) 20.3 (11.0, 25.2) 31.6 (15.2, 37.3)
Coefficient of
variation [%]
6.2 (4.8, 9.7) 13.1 (10.4, 21.8) 23.8 (19.6, 43.0)
Values were calculated from logarithmically-transformed data. Values are
expressed as means (95% Confidence Interval). LF75, LF50 and LF25 denote the
transfer function modulus obtained from the respective percentile segments of
the low-frequency transfer function (see Methods).
doi:10.1371/journal.pone.0079513.t004
Pharmacological and Spectral Baroreflex
PLOS ONE | www.plosone.org 10 November 2013 | Volume 8 | Issue 11 | e79513
lower segments of the low-frequency modulus curve resulted in a
significant reduction in the systematic difference between the
transfer function modulus and the modified Oxford gain (see
Figure 6–7 and Table 1–2).
The frequency dependent increase in transfer function modulus,
that underlies the systematic difference between the two baroreflex
methods, also highlights an important physiological characteristic
of the baroreflex. The present data suggest that the blood pressure
and RR interval change in the modified Oxford method
corresponds to a low frequency RR interval and blood pressure
fluctuation, while the transfer function method encompasses a
broader frequency range, including higher frequency components
of RR interval and blood pressure fluctuation that are under
baroreflex control [24,25]. The gradually increasing transfer
function modulus as function of frequency indicates that the
baroreflex operates as a high-pass filter, i.e., its gain increases as
the rate of input signal increases [50]. Thus, the transfer function
method allows the estimation of this frequency dependent
characteristic of the baroreflex. This baroreflex feature has been
documented earlier in animal studies [51,52] and the rate
sensitivity of baroreflex has also been demonstrated in humans
[53].
The present data can also be viewed within the context of
studies suggesting that the difference between the high-frequency
and low-frequency spectral baroreflex estimates may in part be
because a large portion of the RR variability in the high-frequency
band is unrelated to pressure changes, i.e., not mediated by
baroreflex [46,49] and thus may artificially increase the transfer
function estimate [54]. It is possible that the high-pass filter
characteristic of baroreflex contributes to this observed difference
between spectral indices derived in the high-frequency band and
in the low-frequency band. We also note that, the modulus
calculated from the lowest segment of the low-frequency range (see
25th percentile results) was lower than the mean modified Oxford
gain across subjects. These data suggest that the corresponding
frequency range for the modified Oxford related blood pressure
and RR interval change is around 0.0960.02 Hz, which is defined
by the 50th percentile of the modulus curve.
Random variance
The random variance or error between two measurements
reflects methodological and biological variation occurring from
measurement to measurement [34,36]. Prior studies comparing
baroreflex assessment methods typically found considerable
random variance between the pharmacological and transfer
function baroreflex measures which was usually reported as a
large limit of agreement [29,30,43]. The large random variance
between the modified Oxford gain and the low-frequency transfer
function modulus that we observed in the present study is
consistent with these earlier studies. However, in the present study
we also observed that the random variance between the two
baroreflex measures decreased when the systematic bias between
the two methods was reduced (see Figure 6–7 and Table 1–2). The
random variance (error) between the modified Oxford gain and
the low-frequency transfer modulus decreased from ,30% to
,20% as the systematic difference was reduced too (Table 2). This
,10% decrease in the random variance between the modified
Oxford gain and the transfer function modulus was comparable to
the random variance that we observed between the low-frequency
modulus and the modulus from the lower transfer function
segment (Table 4) – which reflects purely the effect of the
increasing modulus. This suggests that the frequency dependent
increase of transfer function modulus, which causes the systematic
difference between the two methods, inflates the random variance
between the two baroreflex assessment methods.
Limitation
In the present study, we used the standard coherence criterion
(.0.5) method [39] to calculate transfer function modulus over the
low-frequency band. Recent studies, however, have suggested that
the coherence function can overestimate the role of the baroreflex
in the interaction between RR interval and arterial pressure
variability due to the co-existence of feedback and feed forward
mechanisms and the involvement of other non-baroreflex mech-
anisms in the synchronous changes of RR interval and blood
pressure [49,55,56]. In the present study, we focused exclusively
on low-frequency transfer function, and in agreement with the
literature we assumed that the RR interval in our middle-aged
healthy subjects was mainly driven by the blood pressure
variations in the low-frequency range [48,49,56,57].
Conclusions
The present study provides a new insight into the comparison of
pharmacological and frequency domain baroreflex methods by
demonstrating that the difference between the modified Oxford
baroreflex gain and the transfer function modulus of RR interval
and blood pressure oscillations, at least in part, originates from the
frequency dependent, high-pass filter characteristic of the barore-
flex. While the modified Oxford method derives baroreflex gain by
assessing the changes of RR interval in response to a single large
transient biphasic blood pressure change, the transfer function
between spontaneous blood pressure and RR interval oscillations
assesses the baroreflex across a range of frequencies. Our data
suggest that these two methods for baroreflex assessment provide
complementary information on the baroreflex. The modified
Oxford method assesses the entire baroreflex curve from threshold
to saturation while the transfer function analysis allows the
estimation of the frequency dependent characteristics of barore-
flex. The differences between these methods of baroreflex
assessment may have implications for the study of baroreflex
dysfunction in autonomic and cardiovascular disorders.
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